MedTrace Logo

N\L Ratio Versus L\A Ratio as a Predictor of Morbidity and Mortality in Sepsis and Septic Shock

NCT05825118 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-04-24

No results posted yet for this study

Summary

The aim of the study is to compare between neutrophil lymphocyte ratio and lactate albumin ratio as a predictor of morbidity and mortality in sepsis and septic shock patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Neutrophil/Lymphocyte ratio and lactate/ albumin ratio will be measured in all patients.

Blood will be drawn from peripheral vein, arterial or a central catheter for evaluation of whole blood count, serum lactate and serum albumin.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sabry M Ameen, professor · Tanta University

  • Ahmed A abdelhafez, assist. pro · Tanta University

  • Alaa M Abohagar, lecturer · Tanta University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2023-09-30
Completion
2023-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05825118 on ClinicalTrials.gov